InsidersTradesSigma
Integrated Biopharma INC: directors' dealings · United States · SEC (Form 4)
SEC:integrated-biopharma-inc-36d6cdUS·SEC (Form 4)Mcap 2.5Bn€Industrials
Explore the full insider trade history of Integrated Biopharma INC, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Industrials sector, Integrated Biopharma INC has logged 2 insider filings. Market capitalisation: €2.5bn. The latest transaction was reported on 11 May 2022 — Levée d'options. Among the most active insiders: KAY E GERALD. All data is accessible without an account.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Analyst consensus
4 analystsStrong buy
40.00 €Target 61.00 €74.00 €
Valuation
PER (trailing)13.7x
PER (forward)9.6x
P/Book1.3x
Beta0.45
Balance sheet & cash
Market cap2.46 Bn€
Debt / Equity89%
Profitability & ownership
ROE11.4%
ROA4.2%
% insiders42.8%
% institutions25.7%
Last declaration on 11 May 2022
Declarations0 total
No declarations found
0 of 0 declarations